[{"Assets_0_Q2_USD":33409000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1660000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1650000000.0,"StockholdersEquityConverted_0_Q2_USD":14821000000.0,"StockholdersEquity_0_Q2_USD":14699000000.0,"RevenuesConverted_2_Q2_USD":9350000000.0,"RevenuesConverted_1_Q2_USD":4770000000.0,"NetIncomeLossConverted_2_Q2_USD":2490000000.0,"NetIncomeLossConverted_1_Q2_USD":916000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":2445000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.5,"EarningsPerShareDiluted_1_Q2_USD":0.56,"EarningsPerShareBasic_2_Q2_USD":1.51,"EarningsPerShareBasic_1_Q2_USD":0.56,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.78,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.39,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1644000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1653000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170727"}]